Summary
The human T cell leukemia virus type 1 (HTLV-1) oncoprotein Tax interacts with numerous cellular pathways promoting both the survival and pathogenesis of the virus in the human population. Tax has been studied extensively with respect to its role in transcriptional transactivation and its involvement in the up-regulation of a number of cellular genes during the process of oncogenic transformation. These processes are dependent on Tax localization to the nucleus where it interacts with a number of cellular transcription factors during its course of nuclear action. However, there is mounting evidence suggesting that Tax may shuttle between the nucleus and cytoplasm, localize to several cytoplasmic organelles with subsequent secretion from both Tax-transfected cells as well as HTLV-1-infected cells. In addition, the presence of cell-free Tax in cerebral spinal fluid (CSF) was recently demonstrated to occur during all stages of HAM/TSP. This has brought about an increased interest in the cytoplasmic localization of Tax and the implications this localization may have with respect to the progression of HTLV-1-associated disease processes. This review addresses the functional implications relevant to the localization and accumulation of Tax in the cytoplasm including the Tax amino acid signals and cellular protein interactions that may regulate this process. Specifically, we have discussed three important processes associated with the cytoplasmic localization of Tax. First, the process of Tax shuttling between the nucleus and cytoplasm will be described and how this process may be involved in regulating different transcriptional activation pathways. Second, cytoplasmic localization of Tax will be discussed with relevance to Tax secretion and the interaction of Tax with proteins in the cellular secretory pathway. Finally, the secretion of Tax and the effects of extracellular Tax on HTLV-1 pathogenesis will be addressed.
Similar content being viewed by others
References
1. Azran I., Jeang KT., Aboud M., (2005) High levels of cytoplasmic HTLV-1 Tax mutant proteins retain a Tax-NF-kappaB-CBP ternary complex in the cytoplasm. Oncogene, 24: 4521–4530
2. Alefantis T., Barmak K., Harhaj E. W., Grant C., Wigdahl B., (2003). J Biol Chem, 278: 21814–21822
3. Alefantis T., Mostoller K., Jain P., Harhaj E. W., Grant C., Wigdahl B. (2005). J Biol Chem, 280: 17353–17362
Mostoller K. and Wigdahl B. (2005). Unpublished observation
5. Tajima K., (1990). Int J Cancer, 45: 237–243
6. Bangham C.R., (2000). J Clin Pathol 53: 581–586
7. Shimoyama M., (1991). Br J Haematol, 79: 428–437
8. Cleghorn F.R., Manns A., Falk R., Hartge P., Hanchard B., Jack N., Williams E., Jaffe E., White F., Bartholomew C., et al., (1995). J Natl Cancer Inst, 87: 1009–1014
9. Yamaguchi K., Nishimura H., Kawano F., Kohrogi H., Jono M., Miyamoto Y., Takatsuki K., (1983). Jpn J Clin Oncol, 13 Suppl 2: 189–199
10. Kawano F., Yamaguchi K., Nishimura H., Tsuda H., Takatsuki K., (1985). Cancer 55: 851–856
11. Uchiyama T., (1997). Annu Rev Immunol, 15: 15–37
12. Mahieux R., Hermine O., (2005). Leuk Lymphoma, 46: 347–355
Shimoyama M. (1994). In: Takatsuki K. (eds) Adult T cell Leukemia. Oxford University Press, New York, pp. 22–23
Matsuoka M., Takatsuki K. (2002). In: Henderson E.S., Lister T.A., Greaves M.F. (eds) Leukemia. Saunders, Philadelphia, pp. 705–712
15. Matsuoka M., (2005). Retrovirology, 2: 27
16. Ratner L., (2004). Front Biosci, 9: 2852–9
17. Ishikawa T., (2003). Int J Hematol, 78: 304–311
18. Bazarbechi A., Ghez D., Lepelletier Y., Nasr R., DeThe H., El-Sabban M.E., Hermine O., (2004). Lancet Oncol, 5: 664–672
19. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., and Tara M., (1986). Lancet, 1: 1031–1032
20. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., DeThe G., (1985). Lancet, 2: 407–410
21. Levin M.C., Jacobson S., (1997). J Neurovirol, 3: 126–140
22. Osame M., Izumo S., Igata A., Matsumoto M., Matsumoto T., Sonoda S., Tara M., Shibata Y., (1986). Lancet, 2: 104–105
23. Gout O., Baulac M., Gessain A., Semah F., Saal F., Peries J., Cabrol C., Foucault-Fretz C., Laplane D., Sigaux F., et al., (1990). N Engl J Med, 322: 383–388
Osame M., McArthur J.C., (1990). In: Asbury A.K., McKahann G.M. and McDonald W.I. (eds) Diseases of the nervous system: Clinical neurobiology. WB Saunders, New York, pp. 1331–1339
25. McFarlin D.E., Blattner W.A., (1991). Annu Rev Med 42: 97–105
26. Hollsberg P., Hafler D.A., (1993). N Engl J Med, 328: 1173–1182
27. Nakagawa M., Izumo S., Ijichi S., Kubota H., Arimura K., Kawabata M., Osame M., (1995). J Neurovirol, 1: 50–61
28. Osame M., Janssen R., Kubota H., Nishitani H., Igata A., Nagataki S., Mori M., Goto I., Shimabukuro H., Khabbaz R., et al., (1990). Ann Neurol 28: 50–56
29. Elovaara I., Koenig S., Brewah A.Y., Woods R.M., Lehky T., Jacobson S., (1993). J Exp Med, 177: 1567–1573
30. Elovaara I., Utz U., Smith S., Jacobson S., (1995). J Neuroimmunol, 63: 47–53
31. Daenke S., Kermode A.G., Hall S.E., Taylor G., Weber J., Nightingale S., Bangham C.R., (1996). Virology, 217: 139–146
32. Kubota R., Nagai M., Kawanishi T., Osame M., Jacobson S., (2000). AIDS Res Hum Retroviruses, 16: 1705–1709
33. Levin M.C., Lee S.M., Kalume F., Morcos Y., Dohan F.C., Jr., Hasty K.A., Callaway J.C., Zunt J., Desiderio D., Stuart J.M., (2002). Nat Med, 8: 509–513
34. Levin M.C., Lee S.M., Morcos Y., Brady J., Stuart J., (2002). J Infect Dis, 186: 1514–1517
35. Jeffery K.J., Usuku K., Hall S.E., Matsumoto W., Taylor G.P., Procter J., Bunce M., Ogg G.S., Welsh K.I., Weber J.N., Lloyd A.L., Nowak M.A., Nagai M., Kodama D., Izumo S., Osame M., Bangham C.R., (1999). Proc Natl Acad Sci U S A, 96: 3848–3853
36. Furukawa Y., Yamashita M., Usuku K., Izumo S., Nakagawa M., Osame M., (2000). J Infect Dis, 182: 1343–1349
37. Barmak K., Harhaj E.W., Wigdahl B., (2003). J Neurovirol, 9: 522–529
38. Sodroski J.G., Rosen C.A., Haseltine W.A., (1984). Science, 225: 381–385
39. Sodroski J., Rosen C., Goh W.C., Haseltine W., (1985). Science, 228: 1430–1434
40. Harhaj E.W., Sun S.C., (1999). J Biol Chem, 274: 22911–22914
41. Jin D.Y., Giordano V., Kibler K.V., Nakano H., Jeang K T., (1999). J Biol Chem, 274: 17402–17405
42. Harhaj E.W., Harhaj N.S., Grant C., Mostoller K., Alefantis T., Sun S.-C., Wigdahl B., (2005). Virology 333: 145–158
43. Smith M.R., Greene W.C., (1992). Virology 187: 316–320
44. Gitlin S.D., Lindholm P.F., Marriott S.J., Brady J.N., (1991). J Virol, 65: 2612–2621
45. Semmes O.J., Jeang K.T., (1996). J Virol, 70: 6347–6357
46. Bex F., McDowall A., Burny A., Gaynor R., (1997). J Virol, 71: 3484–3497
47. Smith M.R., Greene W.C., (1990). Genes Dev, 4: 1875–1885
48. Nicot C., Tie F., Giam C.Z., (1998). J Virol, 72: 6777–6784
49. Burton M., Upadhyaya C.D., Maier B., Hope T.J., Semmes O.J., (2000). J Virol 74: 2351–2364
50. Szymocha R., Brisson C., Bernard A., Akaoka H., Belin M.F., Giraudon P., (2000). J Neurovirol 6: 350–357
51. Yao Y., Kuo Y.L., Wang L., Harrod R., Tang Y., Cai P., Harrington W., Boros I., Shih H., Giam C.Z., (2000). Leukemia 14: 535
52. Cheng H., Cenciarelli C., Shao Z., Vidal M., Parks W.P., Pagano M., Cheng-Mayer C., (2001). Curr Biol 11: 1771–1775
Alefantis T. and Wigdahl B., Unpublished observations
54. Holaska J.M., Black B.E., Love D.C., Hanover J.A., Leszyk J., Paschal B.M., (2001). J Cell Biol 152: 127–140
55. Holaska J.M., Black B.E., Rastinejad F., Paschal B.M., (2002). Mol Cell Biol 22: 6286–6297
56. Zhang W., Nisbet J.W., Albrecht B., Ding W., Kashanchi F., Bartoe J.T., Lairmore M.D., (2001). J Virol 75: 9885–9895
57. Craig E., Zhang Z.K., Davies K.P., Kalpana G.V., (2002). Embo J, 21: 31–42
58. Dhib-Jalbut S., Hoffman P.M., Yamabe T., Sun D., Xia J., Eisenberg H., Bergey G., Ruscetti F.W., (1994). Ann Neurol 36: 787–790
59. Cowan E.P., Alexander R.K., Daniel S., Kashanchi F., Brady J.N., (1997). J Virol, 71: 6982–6989
60. Cartier L., Ramirez E., (2005). Arch Virol 150: 743–753
61. Lindholm P.F., Marriott S.J., Gitlin S.D., Bohan C.A., Brady J.N., (1990). New Biol 2: 1034–1043
62. Lippincott-Schwartz J., Smith C.L., (1997). Curr Opin Neurobiol, 7: 631–639
63. Lippincott-Schwartz J., Roberts T.H., Hirschberg K., (2000). Annu Rev Cell Dev Biol 16: 557–589
64. Bannykh S.I., Balch W.E., (1998). Histochem Cell Biol 109: 463–475
65. Bannykh S.I., Nishimura N., Balch W.E., (1998). Trends Cell Biol 8: 21–25
66. Nishimura N., Bannykh S., Slabough S., Matteson J., Altschuler Y., Hahn K., Balch W.E., (1999). J Biol Chem 274: 15937–15946
67. Sevier C.S., Weisz O.A., Davis M., Machamer C.E., (2000). Mol Biol Cell 11: 13–22
68. Emanuelsson O., Nielsen H., Brunak S., von Heijne G., (2000). J Mol Biol 300: 1005–1016
69. Rubartelli A., Cozzolino F., Talio M., Sitia R., (1990). Embo J 9: 1503–1510
70. Trowbridge I.S., Collawn J.F., Hopkins C.R., (1993). Annu Rev Cell Biol 9: 129–161
71. Marks M.S., Woodruff L., Ohno H., Bonifacino J.S., (1996). J Cell Biol 135: 341–354
72. Marks M.S., Ohno H., Kirchhausen T., Bonifacino J.S., (1997). Trends in Cell Biology, 7: 124–128
73. Hoffman P.M., Dhib-Jalbut S., Mikovits J.A., Robbins D.S., Wolf A.L., Bergey G.K., Lohrey N.C., Weislow O.S., Ruscetti F.W., (1992). Proc Natl Acad Sci U S A 89: 11784–11788
74. Szymocha R., Akaoka H., Brisson C., Beurton-Marduel P., Chalon A., Bernard A., Didier-Bazes M., Belin M.F., Giraudon P., (2000). AIDS Res Hum Retroviruses 16: 1723–1729
75. Szymocha R., Akaoka H., Dutuit M., Malcus C., Didier-Bazes M., Belin M.F., Giraudon P., (2000). J Virol 74: 6433–6441
76. Lehky T.J., Fox C.H., Koenig S., Levin M.C., Flerlage N., Izumo S., Sato E., Raine C.S., Osame M., Jacobson S., (1995). Ann Neurol 37: 167–175
77. Calegari F., Coco S., Taverna E., Bassetti M., Verderio C., Corradi N., Matteoli M., Rosa P., (1999). J Biol Chem 274: 22539–22547
78. Volknandt W., Kuster F., Wilhelm A., Obermuller E., Steinmann A., Zhang L., Zimmermann H., (2002). Cell Mol Neurobiol 22: 153–169
79. Mor-Vaknin N., Turgeman H., Torgeman A., Wolfson M., Huleihel M., Aboud M., (1998). Cell Biol Int. 22: 95–103
80. Brady J.N., (1992). AIDS Res Hum Retroviruses 8: 724–727
81. Selmaj K.W., Raine C.S., (1988). Ann Neurol 23: 339–346
82. Mostoller K., Norbury C., Jain P., Wigdahl B., (2004). J Neurovirol 10: 1–14
83. Lindholm P.F., Reid R.L., Brady J.N., (1992). J Virol. 66: 1294–1302
Alberts B., Bray D., Lewis J., Raff M., Roberts K. and Watson J., IN: Alberts, B., (Ed), Molecular Biology of the Cell, 9th ed., Garland Publishing, New York, 2002
Acknowledgements
These studies were supported by a grant awarded to Brian Wigdahl from the United States Public Health Service/National Institutes of Health (USPHS/NIH CA54559) and by a Ruth L. Kirschstein National Research Service Award awarded to Kate Mostoller (1 F31 NS 044801).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alefantis, T., Jain, P., Ahuja, J. et al. HTLV-1 Tax nucleocytoplasmic shuttling, interaction with the secretory pathway, extracellular signaling, and implications for neurologic disease. J Biomed Sci 12, 961–974 (2005). https://doi.org/10.1007/s11373-005-9026-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11373-005-9026-x